Evidence map›Paper›PMID 37861938›Full record

ArticleMagma (New York, N.Y.)2024

Synthesis and evaluation of new magneto-fluorescent carbon dot based on manganese citrate for MRI imaging.

Vahid Ali, Hassan Kefayati, Mehdi Shafiee Ardestani, Afshin Pourahmad

Abstract read
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Vahid AliDepartment of Chemistry, Islamic Azad University, Rasht Branch, Rasht, Iran.
Hassan KefayatiDepartment of Chemistry, Islamic Azad University, Rasht Branch, Rasht, Iran. shafieeardestani@gmail.com.
Mehdi Shafiee ArdestaniFaculty of Pharmacy, Department of Radiopharmacy, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-0097-9779
Afshin PourahmadDepartment of Chemistry, Islamic Azad University, Rasht Branch, Rasht, Iran.
Islamic Azad University Rasht Branch · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMedical imaging techniques have widely revolutionized the diagnosis and treatment of various health conditions. Among these techniques, magnetic resonance imaging (MRI) has stood out as a noninvasive and versatile tool. Now, a breakthrough innovation called "manganese-carbon dots" is poised to enhance MRI imaging and provide physicians with even greater insight into the human body. MATERIALS AND

methodsIn this study, one-pot hydrothermal method was used to fabricate magneto-fluorescent carbon quantum dots using manganese citrate, urea, and Mn2+. Manganese citrateAQ3 acted as a carbon source and contrast agent. TEM,XPS, FTIR, UV-Vis, fluorescent analysis confirmed the successful synthesis of magneto-fluorescent carbon quantum dots. The MTT assay was used to study its biocompatiblity, Finallay application of itscompound for mri imaging was investigated.

resultsCharacterization Techniques confirmed the succesful synthesis of product. MTT assay showed no toxicity of this product on HEK-293 cells. In addition, it exhibited high r1 relaxivity (7.4 mM-1 S-1) suggesting excellent potential of magneto-fluorescent carbon quantum dots as MRI T1 contrast agent and enabling specific imaging.

conclusionBased on the results obtained, the synthesized carbon quantum dots could be used as fluorescence/MRI bimodal platform for in vivo imaging.

Indexed as

Contrast MediaManganeseCarbonCitratesHEK293 CellsHumansMagnetic Resonance ImagingCarbonCitratesContrast MediaManganeseCarbon dotMagnetic resonance imagingMagneto-fluorescentManganese citrate

Identifiers

PMID37861938
OpenAlexW4387798913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.